Sigalit Shavit - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Reporting relationship: Chief Information Officer
Issuer ticker: CLBT
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:25:04 UTC
Source filing: View source filing
Reporting owner signature: /s/ Sigalit Shavit

Key filing fact

Sigalit Shavit filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.

Key facts

This page summarizes Sigalit Shavit's Form 3 filing for Cellebrite DI Ltd. (CLBT).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 08:25.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002041387 Primary reporting owner

Shavit Sigalit

Relationship: Chief Information Officer
Address: 94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature: /s/ Sigalit Shavit
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT holding

Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 82,738
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLBT holding Derivative

Stock options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 31,421
Exercise price: $12.73
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Includes 19,560 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on August 8, 2024, of which 1,956 vest on each of May 8, 2026 and every three months thereafter through August 8, 2028. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Footnote F2

Includes 3,132 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 261 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029.

Footnote F3

Includes 11,740 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on August 8, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through August 8, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.

Footnote F4

Includes 31,593 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 7,905 vest on the one year anniversary of the grant date and 1,974 vest every three months thereafter through February 10, 2030.

Footnote F5

Of these stock options, 11,791 are fully vested and exercisable and 1,963 vest on each of May 8, 2026 and every three months thereafter through August 8, 2028.